The accuracy of the National Early Warning Score 2 in predicting early death in prehospital and emergency department settings: a systematic review and meta-analysis
Highlight box
Key findings
• NEWS2 has excellent sensitivity and specificity in predicting 2-day mortality, but a poor sensitivity and specificity for predicting in-hospital, 30-day mortality in the prehospital setting and emergency room.
What is known and what is new?
• EWS, NEWS, and MEWS et al. are used to perform a simple, rapid, effective, and accurate on-site assessment of patients to judge their severity of illness.
• Based on the updated version of NEWS2, we aimed to confirm and describe the sensitivity, specificity, PLR, NLR, DOR, and AUC of NEWS2 for 2-day mortality, 30-day mortality, and in-hospital mortality in the prehospital setting and emergency department at different ‘cutoff’ values.
What is the implication, and what should change now?
• Our results support the use of NEWS2 as a tracking and triggering aid in the assessment of conditions and the allocation of emergency resources when prescreening and triaging patients in prehospital and emergency settings.
Introduction
The prehospital setting and emergency rooms are areas with high demand for emergency care, where patients are characterized by critical conditions, multiple disease comorbidities, sudden onset, and rapid change of condition (1-6). Recognizing and responding to clinical deterioration is a priority for patient safety, as well as for emergency care research (7-9). Numerous studies have shown that during emergency care for deteriorating patients, failure to recognize early symptoms and provide intervention is associated with an increase in high mortality adverse events (10-14). Many scoring systems, such as Early Warning Score (EWS), National Early Warning Score (NEWS), and Modified Early Warning Score (MEWS), are used to perform a simple, rapid, effective, and accurate on-site assessment of patients to judge their severity of illness. However, these scoring systems have shown many shortcomings over time (15). Thus, it is necessary to introduce newer and improved triage systems. To optimize the initial treatment management of patients, ensure the reasonable allocation of resources, and reduce the incidence of mortality.
In December 2017, the National Early Warning Score 2 (NEWS2) was published by the Royal College of Physicians (RCP) as an improved update to NEWS 2012. In January 2019, NEWS2 was rolled out across the National Health Service (NHS) in England (16). NEWS2 contains six physiological parameters, and each parameter is scored from 0 (the least severe) to 3 (the most severe). Compared to NEWS, NEWS2 provides a better prediction of exacerbation in patients with hypercapnia respiratory failure. In chronic obstructive pulmonary disease (COPD) patients with hypercapnia, the use of an oxygen saturation metric score scale remains controversial (17).
The EWS score has been used in multiple health care settings, including hospital wards, emergency departments, and the prehospital community (15). Many studies have explored the accuracy of the National Early Warning Score 2 (NEWS2) in predicting mortality in prehospital and emergency settings, but their findings are inconsistent. Medina-Lozano et al. (18), for instance, found that the sensitivity, specificity, and area under curve (AUC) of NEWS2 in predicting 2-day mortality were 1.0, 0.89, and 0.962, respectively. On the contrary, Martín-Rodríguez et al. (19) reported that the sensitivity, specificity, and AUC of NEWS2 in predicting 2-day mortality were 0.67, 0.75, and 0.756, respectively. The inconsistent findings may be attributable to their different cut-off values of NEWS2. The former adopted a cut-off value of 8 points, whereas the latter used a 11-point cut-off. Whether NEWS2 is reliable for the pre-examination and triage of patients in the prehospital settings and emergency departments remains debatable. This systematic review and meta-analysis aimed to confirm and describe the sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and AUC of NEWS2 for 2-day mortality, 30-day mortality, and in-hospital mortality in the prehospital setting and emergency department at different ‘cutoff’ values. We present the following article in accordance with the PRISMA-DTA reporting checklist (20) (available at https://atm.amegroups.com/article/view/10.21037/atm-22-6587/rc).
Methods
Study design
A predefined protocol has been registered in PROSPERO (CRD42022377935).
Study selection and data extraction
We systematically searched PubMed, Embase, Cochrane Library, Web of Science, CNKI, Wan Fang Data, Vip Database and SinoMed from the inception of each database to January 2023. The specific search strategies are shown in Appendix 1. All studies were screened through EndNote X9. Two authors independently removed duplicates, screened titles, abstracts, and full texts, and agreed on final study eligibility.
The basic inclusion criteria of the literature search included the following: (I) patients in the prehospital or emergency department area were recruited by the study; (II) the NEWS2 for predicting 2-day mortality, 30-day mortality, and in-hospital mortality was applied by the study; (III) sufficient data, such as sensitivity, specificity, overall survival, and deaths, were provided for the study; and (IV) the type of study was accuracy prediction study. The exclusion criteria were as follows: (I) the article was written in a language other than English; (II) insufficient data in the study to calculate the true positive (TP), false-positive (FP), false-negative (FN) and true negative (TN) results; (III) letters, case reports, conferences, meta-analysis, and reviews; and (IV) NEWS2 limited to a composite outcome [e.g., combination of in-hospital mortality with intensive care unit (ICU) admission, adverse outcomes], and (V) the study subjects were animal studies.
Two authors independently extracted data, including authors, year of publication, country of origin, study design, sample size, threshold cutoff values of NEWS2, and mortality (e.g., in-hospital mortality, 2-day mortality, 30-day mortality). If multiple threshold values for NEWS2 were reported in one study, we preferred the maximum value for analyses. If any two researchers had discrepancies during literature screening or data extraction, we resolved them through discussion with the third author.
Risk of bias in the included studies
Two authors independently assessed the risk of bias using the prediction model risk of bias assessment tool (PROBAST). This assessment tool comprises 20 signaling questions in four domains: participants, predictors, outcomes, and analysis. When all 20 questions were answered as yes, the overall risk of bias was rated as low; otherwise, the overall risk of bias was graded at high. Thirteen of the included studies were considered to have a high risk of bias due to inappropriate data sources, such as retrospective cohort studies. When the included studies were of low quality, our pooled data were compromised to some extent. Any disagreement was resolved through discussion. All details of the quality assessment criteria are reported in Appendix 2.
Statistical analysis
When the I2 was equal to or higher than 50%, a random-effects model was used for data analysis; otherwise, a fixed-effects model was adopted. A two-tailed P value <0.05 indicated a statistical difference. The summary area under the curve (SAUC) was pooled as point estimates with 95% confidence intervals (CIs). The summary point estimates of sensitivity and specificity were illustrated through the summary receiver operating characteristic (SROC) curve. In general, when the AUC is 0.5, the diagnostic test has no diagnostic value, 0.7 to 0.8 is considered as acceptable, 0.8 to 0.9 is considered as excellent, and greater than 0.9 has outstanding accuracy (21). We considered sensitivity and specificity greater than 0.8 as an excellent prediction threshold. A significant heterogeneity may affect our results. Hence, we conducted a subgroup analysis according to different thresholds (≥4 vs. ≥9) and studied continents (Europe vs. other continents) to explore the source of heterogeneity. We used Deek’s test for funnel plot asymmetry to assess publication bias (22). All the statistical analyses were conducted using Stata SE 15.1 (Stata Corp. LD, College Station, Texas, USA).
Results
Included studies and their characteristics
A total of 1,458 articles were identified initially, of which 464 articles were duplicated, and 994 were screened out through titles and abstracts. The remaining 82 were considered for a full-text review. After excluding 52 studies, the remaining 30 original studies were included in the final synthesis (the reasons for exclusion are given in Figure 1).
All characteristics of the 30 included studies involving 185,835 participants are shown in Table 1. Among all the included studies, the lowest cutoff value of NEWS2 was greater than 1, and the highest cutoff value of NEWS2 was greater than 11. Three studies were from Asia, and the countries were China (24), India (26), and Japan (33). Two studies were from North America, including Canada (31) and United States (32). Twenty-five studies were from Europe, and the countries were the United Kingdom, Italy, Spain, and Sweden, of which five studies (23,28-30,34) belonged to the United Kingdom, fifteen (18-19,27,35-40,42-43,47-50) to Spain, two (25,,45) to Italy, and three (41,44,46) to Sweden. In addition, seventeen studies (18-19,26-27,35,37-44,46-50) were prospective, and the other 13 studies were retrospective. All included studies took place from 2019 to 2022.
Table 1
References | Year | Country | Design | Sample size | Cutoff | Outcome |
---|---|---|---|---|---|---|
Medina-Lozano et al. (18) | 2020 | Spain | Prospective | 346 | 8 | 2-day mortality |
Martín-Rodríguez et al. (19) | 2020 | Spain | Prospective | 3,081 | 11 | 2-day mortality |
Marincowitz et al. (23) | 2022 | England | Retrospective | 7,549 | 1 | 30-day mortality |
Hu et al. (24) | 2022 | China | Retrospective | 319 | 10 | In-hospital mortality |
Guarino et al. (25) | 2022 | Italy | Retrospective | 437 | 7 | In-hospital mortality, 30-day mortality |
Chikhalkar et al. (26) | 2022 | Indian | Prospective | 814 | 9 | In-hospital mortality |
Villanueva Rábano et al. (27) | 2021 | Spain | Prospective | 638 | 10 | 2-day mortality |
9 | 30-day mortality | |||||
Thomas et al. (28) | 2021 | UK | Retrospective | 20,891 | 4 | 30-day mortality |
Sivayoham et al. (29) | 2021 | UK | Retrospective | 2,594 | 8 | In-hospital mortality |
Richardson et al. (30) | 2021 | England | Retrospective | 6,444 | 5 | In-hospital mortality, 2-day mortality |
Reardon et al. (31) | 2021 | Canada | Retrospective | 4,022 | 5 | In-hospital mortality |
Prasad et al. (32) | 2021 | America | Retrospective | 23,837 | 5 | In-hospital mortality |
Osawa et al. (33) | 2021 | Japan | Retrospective | 2,900 | 6 | In-hospital mortality |
Masson et al. (34) | 2021 | England | Retrospective | 91,871 | 5 | 2-day mortality, 30-day mortality |
Martín-Rodríguez et al. (35) | 2021 | Spain | Prospective | 3,273 | 7 | 2-day mortality |
Martín-Rodríguez et al. (36) | 2021 | Spain | Retrospective | 663 | 7 | 2-day mortality |
López-Izquierdo et al. (37) | 2021 | Spain | Prospective | 941 | 8 | 30-day mortality |
Durantez-Fernández et al. (38) | 2022 | Spain | Prospective | 1,716 | 6.5 | 2-day mortality |
5.5 | 30-day mortality | |||||
Durantez-Fernández et al. (39) | 2021 | Spain | Prospective | 445 | 6 | 2-day mortality |
5 | 30-day mortality | |||||
Clar et al. (40) | 2021 | Spain | Prospective | 201 | 5 | In-hospital mortality |
Mellhammar et al. (41) | 2020 | Sweden | Retrospective | 941 | 5 | 30-day mortality |
Martín-Rodríguez et al. (42) | 2020 | Spain | Prospective | 209 | 10 | 2-day mortality |
Martín-Rodríguez et al. (43) | 2020 | Spain | Prospective | 2,335 | 9 | 2-day mortality |
7 | 30-day mortality | |||||
Magnusson et al. (44) | 2020 | Sweden | Prospective | 4,465 | 5 | 2-day mortality, 30-day mortality |
Covino et al. (45) | 2020 | Italy | Retrospective | 334 | 4 | 2-day mortality |
Mellhammar et al. (46) | 2019 | Sweden | Prospective | 1,171 | 5 | 30-day mortality |
Martín-Rodríguez et al. (47) | 2019 | Spain | Prospective | 1,054 | 9 | 2-day mortality |
Martín-Rodríguez et al. (48) | 2019 | Spain | Prospective | 707 | 9 | 2-day mortality |
8 | 30-day mortality | |||||
Martín-Rodríguez et al. (49) | 2019 | Spain | Prospective | 349 | 10 | 2-day mortality |
Martín-Rodríguez et al. (50) | 2019 | Spain | Prospective | 1,288 | 9 | 2-day mortality |
Quality assessment
The summary of quality assessment using PROBAST is shown in Table 2. Overall, 13 retrospective cohort studies (23-25,28-34,36,41,45) had a high risk of bias, principally because we assumed that subjects had systematic differences in the accuracy of reporting past information, resulting in recall bias (51,52). The details of the quality assessment are recorded in Appendix 2.
Table 2
References | ROB | Applicability | Overall | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Participants | Predictors | Outcome | Analysis | Participants | Predictors | Outcome | ROB | Applicability | |||
Medina-Lozano et al. 2020 (18) | + | + | + | + | + | + | + | + | + | ||
Martín-Rodríguez et al. 2020 (19) | + | + | + | + | + | + | + | + | + | ||
Marincowitz et al. 2022 (23) | − | + | + | + | + | + | + | − | + | ||
Hu et al. 2022 (24) | − | + | + | + | + | + | + | − | + | ||
Guarino et al. 2022 (25) | − | + | + | + | + | + | + | − | + | ||
Chikhalkar et al. 2022 (26) | + | + | + | + | + | + | + | + | + | ||
Villanueva Rábano et al. 2021 (27) | + | + | + | + | + | + | + | + | + | ||
Thomas et al. 2021 (28) | − | + | + | + | + | + | + | − | + | ||
Sivayoham et al. 2021 (29) | − | + | + | + | + | + | + | − | + | ||
Richardson et al. 2021 (30) | − | + | + | + | + | + | + | − | + | ||
Reardon et al. 2021 (31) | − | + | + | + | + | + | + | − | + | ||
Prasad et al. 2021 (32) | − | + | + | + | + | + | + | − | + | ||
Osawa et al. 2021 (33) | − | + | + | + | + | + | + | − | + | ||
Masson et al. 2021 (34) | − | + | + | + | + | + | + | − | + | ||
Martín-Rodríguez et al. 2021 (35) | + | + | + | + | + | + | + | + | + | ||
Martín-Rodríguez et al. 2021 (36) | − | + | + | + | + | + | + | − | + | ||
López-Izquierdo et al. 2021 (37) | + | + | + | + | + | + | + | + | + | ||
Durantez-Fernández et al. 2022 (38) | + | + | + | + | + | + | + | + | + | ||
Durantez-Fernández et al. 2021 (39) | + | + | + | + | + | + | + | + | + | ||
Clar et al. 2021 (40) | + | + | + | + | + | + | + | + | + | ||
Mellhammar et al. 2020 (41) | − | + | + | + | + | + | + | − | + | ||
Martín-Rodríguez et al. 2020 (42) | + | + | + | + | + | + | + | + | + | ||
Martín-Rodríguez et al. 2020 (43) | + | + | + | + | + | + | + | + | + | ||
Magnusson et al. 2020 (44) | + | + | + | + | + | + | + | + | + | ||
Covino et al. 2020 (45) | − | + | + | + | + | + | + | − | + | ||
Mellhammar et al. 2019 (46) | + | + | + | + | + | + | + | + | + | ||
Martín-Rodríguez et al. 2019 (47) | + | + | + | + | + | + | + | + | + | ||
Martín-Rodríguez et al. 2019 (48) | + | + | + | + | + | + | + | + | + | ||
Martín-Rodríguez et al. 2019 (49) | + | + | + | + | + | + | + | + | + | ||
Martín-Rodríguez et al. 2019 (50) | + | + | + | + | + | + | + | + | + |
‘+’ represents low ROB/low concern regarding applicability; ‘−’ represents high ROB/high concern regarding applicability. PROBAST, Prediction model Risk of Bias Assessment; ROB, risk of bias.
The results of synthesis
The forest plots of sensitivity, specificity, PLR, NLR, and diagnostic odds ratio (DOR) for NEWS2 are illustrated in Figures 2-5 and show the summary ROC (SROC) curves for NEWS2. Overall, the pooled sensitivity, specificity, DOR, and AUC of 2-day mortality were 0.81 (95% CI: 0.76, 0.84), 0.81 (95% CI: 0.78, 0.84), 18 (95% CI: 12, 26), and 0.88 (95% CI: 0.85, 0.90), respectively (Table 3). The pooled sensitivity, specificity, DOR, and AUC of 30-day mortality were 0.76 (95% CI: 0.68, 0.83), 0.69 (95% CI: 0.59, 0.78), 7 (95% CI: 6, 9), and 0.80 (95% CI: 0.76, 0.83), respectively. For in-hospital mortality, the pooled sensitivity, specificity, DOR, and AUC were 0.72 (95% CI: 0.61, 0.80), 0.78 (95% CI: 0.49, 0.93), 9 (95% CI: 3, 28), and 0.78 (95% CI: 0.74, 0.82), respectively.
Table 3
Results | N | Sensitivity (95% CI) | Specificity (95% CI) | PLR (95% CI) | NLR (95% CI) | DOR | AUC (95% CI) |
---|---|---|---|---|---|---|---|
In-hospital mortality | 9 | 0.72 (0.61, 0.80) | 0.78 (0.49, 0.93) | 3.3 (1.3, 8.7) | 0.36 (0.27, 0.48) | 9 (3, 28) | 0.78 (0.74, 0.82) |
2-day mortality | 17 | 0.81 (0.76, 0.84) | 0.81 (0.78, 0.84) | 4.3 (3.5, 5.2) | 0.24 (0.19, 0.30) | 18 (12, 26) | 0.88 (0.85, 0.90) |
30-day mortality | 13 | 0.76 (0.68, 0.83) | 0.69 (0.59, 0.78) | 2.5 (2.0, 3.1) | 0.34 (0.28, 0.42) | 7 (6, 9) | 0.80 (0.76, 0.83) |
Subgroup analysis | |||||||
Threshold value (2-day mortality) | |||||||
NEWS2 ≥4 | 9 | 0.82 (0.77, 0.86) | 0.80 (0.74, 0.85) | 4.0 (3.1, 5.3) | 0.23 (0.17, 0.29) | 18 (11, 29) | 0.88 (0.84, 0.90) |
NEWS2 ≥9 | 8 | 0.78 (0.71, 0.84) | 0.83 (0.79, 0.86) | 4.5 (3.4, 5.8) | 0.27 (0.19, 0.37) | 17 (10, 29) | 0.87 (0.84, 0.90) |
Continent (in-hospital mortality) | |||||||
Europe | 4 | 0.77 (0.55, 0.90) | 0.61 (0.40, 0.78) | 2.0 (1.5, 2.7) | 0.38 (0.24, 0.61) | 5 (4, 7) | 0.74 (0.70, 0.78) |
Other continents | 5 | 0.69 (0.59, 0.78) | 0.90 (0.39, 0.99) | 7.1 (0.7, 70.2) | 0.34 (0.28, 0.43) | 20 (2, 217) | 0.76 (0.72, 0.79) |
CI, confidence interval; PLR, positive likelihood ratio; NLR, negative likelihood ratio; DOR, diagnostic odds ratio; AUC, area under the curve; NEWS2, National Early Warning Score 2.
Subgroup analysis
There is relevant evidence that the prognostic performance of NEWS2 is not significantly different in different subgroups (Table 3). The sensitivity and specificity of the NEWS2 in predicting early mortality (2-day mortality) in prehospital and emergency settings are high, with excellent accuracy. For example, in 9 studies using a threshold ≥4, the pooled sensitivity, specificity and AUC were 0.82 (95% CI: 0.77, 0.86), 0.80 (95% CI: 0.74, 0.85), and 0.88 (95% CI: 0.84, 0.90); in the 8 studies using a threshold ≥9, the combined sensitivity, specificity, and AUC were 0.78 (95% CI: 0.71, 0.84), 0.83 (95% CI: 0.79, 0.86), and 0.87 (95% CI: 0.84, 0.90). In addition, from the pooled data of NEWS2 in different continents for predicting in-hospital mortality in prehospital and emergency settings, the accuracy rate in Europe and other continents is acceptable, with a similar AUC (0.74 vs. 0.76). Among them, the European study had a low sensitivity of 0.77 (95% CI: 0.55, 0.90) and a poor specificity of 0.61 (95% CI: 0.40, 0.78); studies from other continents (Asia, North America) had a low sensitivity of 0.69 (95% CI: 0.59, 0.78) and an outstanding specificity of 0.90 (95% CI: 0.39, 0.99).
The results of publication bias
Figure 6 shows the results of publication bias by using Deeks’ funnel plot asymmetry test. The P values of NEWS2 for patients in 2-day, 30-day, and in-hospital mortality were 0.98, 0.99, and 0.07, respectively. This indicates that there was no significant publication bias.
Discussion
Throughout this systematic review and meta-analysis, we found that the AUC curve of 2-day mortality in the emergency department and the prehospital settings ranged from 0.85 to 0.90. The AUC curves of in-hospital mortality and 30-day mortality ranged from 0.74 to 0.82 and 0.76 to 0.83, respectively. NEWS2 is relatively reliable in identifying early mortality (2-day mortality) in patients in the emergency department and prehospital areas. Analysis of the data shows that the accuracy of NEWS2 in predicting the abovementioned adverse outcomes is acceptable or even excellent. Thus, our results support the use of the NEWS2 as a tracking and triggering aid in the assessment of conditions and the allocation of emergency resources when prescreening and triaging patients in prehospital and emergency settings, especially in crowded emergency rooms (53). In addition, our results also show that NEWS2 is highly sensitive (0.82) in predicting 2-day mortality for results with a threshold ≥4, while the sensitivity of NEWS2 (0.78) decreases in predicting 2-day mortality for results with a threshold ≥9. This means that for patients with a NEWS2 score ≥4, we should increase clinical attention, identify patients with high-risk factors in the population, and provide early intervention as soon as possible to improve the prognosis. NEWS2 is rather stable in predicting the in-hospital mortality rate across different continents, and there is no obvious difference in accuracy.
The pooled results showed significant heterogeneity among the included studies, where I2>50% represented significant heterogeneity (54). The large sample size gap, the different study designs (prospective and retrospective), and the methods of registering the population may be sources of heterogeneity. In addition, we considered that the study location might be a confounding factor for various health care systems, which could influence clinical outcomes. Heterogeneity may also arise due to the various time windows between score calculation and outcome measurement. Since early warning score systems have been introduced in many United Kingdom (UK) hospitals, they have been used for a wide variety of patients clinically and associated with relevant clinical responses (55). Some urgent patients are likely to receive rapid medical care after triggering the alert. The actual death rate tends to be lower than the predicted rate, which may bias our estimate of accuracy and lead to heterogeneity. Furthermore, our study included prehospital and emergency settings, which are different, as well as various outcome measures, such as 2-day mortality, 30-day mortality, and in-hospital mortality. The difference in setting and outcome measures may also explain the source of heterogeneity.
Patients with novel coronavirus-infected pneumonia are usually characterized by solitary respiratory failure (56). Moreover, supplemental oxygen has been confirmed as an independent risk factor for the progression of novel coronavirus pneumonia to critical illness (57). Compared to the original NEWS, NEWS2 has similar sensitivity and specificity to NEWS in predicting non-hypercapnic respiratory failure. In predicting hypercapnic respiratory failure, based on the SPO2 scoring scale specially developed for hypercapnia (58), NEWS2 is better than NEWS. In addition, compared with other scoring systems, such as Early Warning Score (EWS), MEWS, and quick Sepsis related Organ Failure Assessment (qSOFA), the main advantage of NEWS2 is that both hypoxemia and supportive oxygen therapy are included in the scoring parameters. Therefore, although other scoring systems and NEWS2 have good discrimination, sensitivity, and specificity, NEWS2 might be more reliable in prehospital and emergency department settings, especially during the COVID-19 pandemic. In addition, our research suggests that we should activate early medical care for patients with a NEWS2 threshold ≥4 in predicting early mortality (2-day mortality). According to the guidelines of the Royal College of Physicians (59), patients with a NEWS2 score of fewer than 5 points still have the possibility of rapid deterioration, leading to severe respiratory failure. Thus, we need to continuously monitor this subset of patients with a NEWS2 threshold less than 5. Notably, NEWS2 should be utilized to support clinical decision-making by providing objective data, but it should not be an alternative to the clinical judgment of experienced clinicians. Hence, NEWS2 could be used to evaluate a possible deterioration in the patient’s condition throughout their hospital stay.
Strengths and limitations of the review
The current meta-analysis has several strengths. First, we included the most recent cohort study data available in this fast-moving domain, including findings during the COVID-19 pandemic from 2019 to 2022. Second, we focused on the triage performance of the NEWS2 scoring system in the prehospital setting and emergency departments, as both locations have the characteristics of diverse patients and diseases. Thus, our conclusion could more typically represent the accuracy of the scoring system.
Nevertheless, there are some crucial limitations in our research. First, there was significant heterogeneity in our study. One-fifth of the included studies had small sample sizes (<400), and the quality of the included studies was not as high as the reliability of large samples. Second, the meta-analysis did not have sufficient data to explore the performance of NEWS2 in patients younger than 18 years. The age of the study subjects was concentrated in adults. Therefore, using NEWS2 on individuals younger than 18 years of age might lead to inaccurate results. Third, more than two-thirds of the included studies in our research were from Europe. We still need more evidence from non-European countries to improve the accuracy and clinical applicability of NEWS2.
Conclusions
This is the first meta-analysis to assess the accuracy of the NEWS2 in predicting in-hospital, 2-day, and 30-day mortality for patients in the prehospital setting and emergency departments. Based on the AUC, sensitivity, and specificity results greater than 0.8 as an excellent prediction threshold, we comprehensively analyzed the above outcomes. Thus, NEWS2 has excellent sensitivity and specificity in predicting early mortality (2-day mortality) and can reliably identify the patients requiring emergency preparing and response. Our findings underpin the use of NEWS2 as a pre-examination and triage tool to predict early death in the prehospital settings and emergency departments. However, it shows poor performance in predicting in-hospital mortality and 30-day mortality. The predictive performance of NEWS2 is more reliable when the cut-off value is ≥4. Nevertheless, with the increase of score, the predictive performance decrease. Ultimately, ongoing clinical attention is warranted, even though patients with a low NEWS2 score have a reduced risk of death for several days. Besides, to improve the predictive accuracy, NEWS2 should be used to monitor patients continuously rather than at a single point-in-time.
In the future, we hope that there will be more large-scale and high-quality studies on this topic to further inform our results.
Acknowledgments
We would like to thank the researchers and study participants for their contributions.
Funding: None.
Footnote
Reporting Checklist: The authors have completed the PRISMA-DTA reporting checklist. Available at https://atm.amegroups.com/article/view/10.21037/atm-22-6587/rc
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://atm.amegroups.com/article/view/10.21037/atm-22-6587/coif). The authors have no conflicts of interest to declare.
Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Considine J, Jones D, Bellomo R. Emergency department rapid response systems: the case for a standardized approach to deteriorating patients. Eur J Emerg Med 2013;20:375-81. [Crossref] [PubMed]
- Canto JG, Zalenski RJ, Ornato JP, et al. Use of emergency medical services in acute myocardial infarction and subsequent quality of care: observations from the National Registry of Myocardial Infarction 2. Circulation 2002;106:3018-23. [Crossref] [PubMed]
- Burkholder TW, Hill K, Calvello Hynes EJ. Developing emergency care systems: a human rights-based approach. Bull World Health Organ 2019;97:612-9. [Crossref] [PubMed]
- Pinto C, Cameron PA, Gabbe B, et al. Trauma case review: A quality and safety feature of the Victorian State Trauma System. Emerg Med Australas 2018;30:125-9. [Crossref] [PubMed]
- Burrell AR, McLaws ML, Fullick M, et al. SEPSIS KILLS: early intervention saves lives. Med J Aust 2016;204:73. [Crossref] [PubMed]
- National Stroke Foundation. Clinical guidelines for stroke management 2017. Chapter 1 of 8: Pre-hospital care. Retrieved 05 November 2017. Available online: https://informme.org.au/en/Guidelines/Clinical-Guidelines-for-Stroke-Management-2017. Melbourne: National Stroke Foundation, 2017.
- Considine J, Curtis K, Shaban RZ, et al. Consensus-based clinical research priorities for emergency nursing in Australia. Australas Emerg Care 2018;21:43-50. [Crossref] [PubMed]
- Lecky F, Benger J, Mason S, et al. The International Federation for Emergency Medicine framework for quality and safety in the emergency department. Emerg Med J 2014;31:926-9. [Crossref] [PubMed]
- Keijzers G, Thom O, Taylor D, et al. Clinical research priorities in emergency medicine. Emerg Med Australas 2014;26:19-27. [Crossref] [PubMed]
- Hayward RA, Asch SM, Hogan MM, et al. Sins of omission: getting too little medical care may be the greatest threat to patient safety. J Gen Intern Med 2005;20:686-91. [Crossref] [PubMed]
- Stang AS, Wingert AS, Hartling L, et al. Adverse events related to emergency department care: a systematic review. PLoS One 2013;8:e74214. [Crossref] [PubMed]
- Hagiwara MA, Magnusson C, Herlitz J, et al. Adverse events in prehospital emergency care: a trigger tool study. BMC Emerg Med 2019;19:14. [Crossref] [PubMed]
- Considine J, Jones D, Pilcher D, et al. Patient physiological status during emergency care and rapid response team or cardiac arrest team activation during early hospital admission. Eur J Emerg Med 2017;24:359-65. [Crossref] [PubMed]
- Forster AJ, Rose NG, van Walraven C, et al. Adverse events following an emergency department visit. Qual Saf Health Care 2007;16:17-22. [Crossref] [PubMed]
- Guan G, Lee CMY, Begg S, et al. The use of early warning system scores in prehospital and emergency department settings to predict clinical deterioration: A systematic review and meta-analysis. PLoS One 2022;17:e0265559. [Crossref] [PubMed]
- National Early Warning Score (NEWS) 2. Standardising the Assessment of Acute-Illness Severity in the NHS: Updated Report of a Working Party. London: Royal College of Physicians, 2017.
- Smith GB, Redfern OC, Pimentel MA, et al. The National Early Warning Score 2 (NEWS2). Clin Med (Lond) 2019;19:260. [Crossref] [PubMed]
- Medina-Lozano E, Martín-Rodríguez F, Castro-Villamor MÁ, et al. Accuracy of early warning scores for predicting serious adverse events in pre-hospital traumatic injury. Injury 2020;51:1554-60. [Crossref] [PubMed]
- Martín-Rodríguez F, López-Izquierdo R, Delgado Benito JF, et al. Prehospital Point-Of-Care Lactate Increases the Prognostic Accuracy of National Early Warning Score 2 for Early Risk Stratification of Mortality: Results of a Multicenter, Observational Study. J Clin Med 2020;9:1156. [Crossref] [PubMed]
- McInnes MDF, Moher D, Thombs BD, et al. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement. JAMA 2018;319:388-96. [Crossref] [PubMed]
- Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol 2010;5:1315-6. [Crossref] [PubMed]
- Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 2005;58:882-93. [Crossref] [PubMed]
- Marincowitz C, Sutton L, Stone T, et al. Prognostic accuracy of triage tools for adults with suspected COVID-19 in a prehospital setting: an observational cohort study. Emerg Med J 2022;39:317-24. [Crossref] [PubMed]
- Hu H, Yao N, Qiu Y. Predictive Value of 5 Early Warning Scores for Critical COVID-19 Patients. Disaster Med Public Health Prep 2022;16:232-9. [Crossref] [PubMed]
- Guarino M, Perna B, Remelli F, et al. A New Early Predictor of Fatal Outcome for COVID-19 in an Italian Emergency Department: The Modified Quick-SOFA. Microorganisms 2022;10:806. [Crossref] [PubMed]
- Chikhalkar B, Gosain D, Gaikwad S, et al. Assessment of National Early Warning Score 2 as a Tool to Predict the Outcome of COVID-19 Patients on Admission. Cureus 2022;14:e21164. [Crossref] [PubMed]
- Villanueva Rábano R, Martín-Rodríguez F, López-Izquierdo R. National Early Warning Score 2 Lactate (NEWS2-L) in Predicting Early Clinical Deterioration in Patients with Dyspnoea in Prehospital Care. Invest Educ Enferm 2021;39:e05. [Crossref] [PubMed]
- Thomas B, Goodacre S, Lee E, et al. Prognostic accuracy of emergency department triage tools for adults with suspected COVID-19: the PRIEST observational cohort study. Emerg Med J 2021;38:587-93. [Crossref] [PubMed]
- Sivayoham N, Hussain AN, Shabbo L, et al. An observational cohort study of the performance of the REDS score compared to the SIRS criteria, NEWS2, CURB65, SOFA, MEDS and PIRO scores to risk-stratify emergency department suspected sepsis. Ann Med 2021;53:1863-74. [Crossref] [PubMed]
- Richardson D, Faisal M, Fiori M, et al. Use of the first National Early Warning Score recorded within 24 hours of admission to estimate the risk of in-hospital mortality in unplanned COVID-19 patients: a retrospective cohort study. BMJ Open 2021;11:e043721. [Crossref] [PubMed]
- Reardon PM, Seely AJE, Fernando SM, et al. Can Early Warning Systems Enhance Detection of High Risk Patients by Rapid Response Teams? J Intensive Care Med 2021;36:542-9. [Crossref] [PubMed]
- Prasad PA, Fang MC, Martinez SP, et al. Identifying the Sickest During Triage: Using Point-of-Care Severity Scores to Predict Prognosis in Emergency Department Patients With Suspected Sepsis. J Hosp Med 2021;16:453-61. [Crossref] [PubMed]
- Osawa I, Sonoo T, Soeno S, et al. Clinical performance of early warning scoring systems for identifying sepsis among anti-hypertensive agent users. Am J Emerg Med 2021;48:120-7. [Crossref] [PubMed]
- Masson H, Stephenson J. Investigation into the predictive capability for mortality and the trigger points of the National Early Warning Score 2 (NEWS2) in emergency department patients. Emerg Med J 2022;39:685-90. [Crossref] [PubMed]
- Martín-Rodríguez F, Sanz-García A, Medina-Lozano E, et al. The Value of Prehospital Early Warning Scores to Predict in - Hospital Clinical Deterioration: A Multicenter, Observational Base-Ambulance Study. Prehosp Emerg Care 2021;25:597-606. [Crossref] [PubMed]
- Martín-Rodríguez F, Martín-Conty JL, Sanz-García A, et al. Early Warning Scores in Patients with Suspected COVID-19 Infection in Emergency Departments. J Pers Med 2021;11:170. [Crossref] [PubMed]
- López-Izquierdo R, Martín-Rodríguez F, Santos Pastor JC, et al. Can capillary lactate improve early warning scores in emergency department? An observational, prospective, multicentre study. Int J Clin Pract 2021;75:e13779. [Crossref] [PubMed]
- Durantez-Fernández C, Martín-Conty JL, Polonio-López B, et al. Lactate improves the predictive ability of the National Early Warning Score 2 in the emergency department. Aust Crit Care 2022;35:677-83. [Crossref] [PubMed]
- Durantez-Fernández C, Martín-Conty JL, Medina-Lozano E, et al. Early detection of intensive care needs and mortality risk by use of five early warning scores in patients with traumatic injuries: An observational study. Intensive Crit Care Nurs 2021;67:103095. [Crossref] [PubMed]
- Clar J, Oltra MR, Benavent R, et al. Prognostic value of diagnostic scales in community-acquired sepsis mortality at an emergency service. Prognosis in community-adquired sepsis. BMC Emerg Med 2021;21:161. [Crossref] [PubMed]
- Mellhammar L, Linder A, Tverring J, et al. Scores for sepsis detection and risk stratification - construction of a novel score using a statistical approach and validation of RETTS. PLoS One 2020;15:e0229210. [Crossref] [PubMed]
- Martín-Rodríguez F, López-Izquierdo R, Mohedano-Moriano A, et al. Identification of Serious Adverse Events in Patients with Traumatic Brain Injuries, from Prehospital Care to Intensive-Care Unit, Using Early Warning Scores. Int J Environ Res Public Health 2020;17:1504. [Crossref] [PubMed]
- Martín-Rodríguez F, López-Izquierdo R, Del Pozo Vegas C, et al. Can the prehospital National Early Warning Score 2 identify patients at risk of in-hospital early mortality? A prospective, multicenter cohort study. Heart Lung 2020;49:585-91. [Crossref] [PubMed]
- Magnusson C, Herlitz J, Axelsson C. Pre-hospital triage performance and emergency medical services nurse's field assessment in an unselected patient population attended to by the emergency medical services: a prospective observational study. Scand J Trauma Resusc Emerg Med 2020;28:81. [Crossref] [PubMed]
- Covino M, Sandroni C, Santoro M, et al. Predicting intensive care unit admission and death for COVID-19 patients in the emergency department using early warning scores. Resuscitation 2020;156:84-91. [Crossref] [PubMed]
- Mellhammar L, Linder A, Tverring J, et al. NEWS2 is Superior to qSOFA in Detecting Sepsis with Organ Dysfunction in the Emergency Department. J Clin Med 2019;8:1128. [Crossref] [PubMed]
- Martín-Rodríguez F, López-Izquierdo R, Del Pozo Vegas C, et al. A Multicenter Observational Prospective Cohort Study of Association of the Prehospital National Early Warning Score 2 and Hospital Triage with Early Mortality. Emerg Med Int 2019;2019:5147808. [Crossref] [PubMed]
- Martín-Rodríguez F, López-Izquierdo R, Del Pozo Vegas C, et al. Predictive value of the prehospital NEWS2-L —National Early Warning Score 2 Lactate— for detecting early death after an emergency. Emergencias 2019;31:173-9. [PubMed]
- Martín-Rodríguez F, López-Izquierdo R, Del Pozo Vegas C, et al. Accuracy of National Early Warning Score 2 (NEWS2) in Prehospital Triage on In-Hospital Early Mortality: A Multi-Center Observational Prospective Cohort Study. Prehosp Disaster Med 2019;34:610-8. [Crossref] [PubMed]
- Martín-Rodríguez F, Castro-Villamor MÁ, Del Pozo Vegas C, et al. Analysis of the early warning score to detect critical or high-risk patients in the prehospital setting. Intern Emerg Med 2019;14:581-9. [Crossref] [PubMed]
- Sedgwick P. Statistical question. What is recall bias? Br Med J 2012;344: [Crossref]
- Sedgwick P. Retrospective cohort studies: advantages and disadvantages. BMJ-British Medical Journal 2014;348: [Crossref]
- Kenny JF, Chang BC, Hemmert KC. Factors Affecting Emergency Department Crowding. Emerg Med Clin North Am 2020;38:573-87. [Crossref] [PubMed]
- Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58. [Crossref] [PubMed]
- Scott LJ, Redmond NM, Garrett J, et al. Distributions of the National Early Warning Score (NEWS) across a healthcare system following a large-scale roll-out. Emerg Med J 2019;36:287-92. [Crossref] [PubMed]
- Su Y, Ju MJ, Xie RC, et al. Prognostic Accuracy of Early Warning Scores for Clinical Deterioration in Patients With COVID-19. Front Med (Lausanne) 2020;7:624255. [Crossref] [PubMed]
- Sun Q, Qiu H, Huang M, et al. Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province. Ann Intensive Care 2020;10:33. [Crossref] [PubMed]
- Williams B. The National Early Warning Score 2 (NEWS2) in patients with hypercapnic respiratory failure. Clin Med (Lond) 2019;19:94-5. [Crossref] [PubMed]
- NEWS2 and deterioration in COVID-19 2021. Available online: https://www.rcplondon.ac.uk/news/news2-and-deterioration-covid-19